Study record

Relationship between the mitochondria-derived peptide MOTS-c and insulin resistance in obstructive sleep apnea

Baylan FA, Yarar E · Sleep Breath · 2021

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Found lower serum MOTS-c in adults with obstructive sleep apnoea than in healthy controls, with levels decreasing as apnoea severity increased. Reported negative correlations between serum MOTS-c and both apnoea-hypopnoea index and BMI, and an independent association with apnoea-hypopnoea index in regression analysis.

Limitations

Cross-sectional single-centre design with a small control group, a male-predominant sample, and no adjustment described for confounders beyond those entered into the regression; causality cannot be inferred.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedAdults with obstructive sleep apnoea graded by severity and healthy controls
Populationadults with obstructive sleep apnoea (mild, moderate, severe) and healthy controls
DesignCase-control study
Sample size as reported90 participants (70 with OSA, 20 controls)
Control group20 healthy controls with AHI 5 or below
Route (data field only)Not reported
Endpoints measuredserum MOTS-c; apnoea-hypopnoea index; HOMA-IR; BMI; lipid and glucose profile
Pathways measuredInsulin & glucose handling
Research areasMetabolic · Lung
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Limited
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.